Randomized trial demonstrates effective C–O coupling of chiral alcohols with aryl halides, suggesting a new method for drug discovery.
Although photochemically driven earth-abundant nickel catalysis is progressively becoming a major method in constructing carbon-oxygen bonds, there remains a lack of universal strategy that can be broadly applied to the coupling of various chiral alcohols with aryl halides without compromising enantiomeric excess. Herein, we report a light-driven nickel-catalyzed method that achieves stereochemistry-preserving C-O coupling between optically active alcohols with aryl halides, without the need for any external photosensitizer. The method is compatible with a wide range of coupling substrates, including compounds bearing bases and nucleophile-sensitive functional groups, providing a robust route to valuable chiral aryl alkyl ethers. The gram-scale synthesis of fragments of the antidiabetic drug empagliflozin further highlights its applicability and generality in drug discovery.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: